
Liliana E. Pezzin, PhD, JD
Professor, Institute for Health & Equity; Executive Director, Collaborative for Healthcare Delivery Science
Locations
- General Internal Medicine
Contact Information
Biography
Research Interests
Much of Dr. Pezzin’s research effort focuses on issues related to long-term care, aging and disability, with special emphasis on the interplay between public policy and family behavior. She recently concluded work as principal investigator on an NIA-funded grant examining the relationship between state long-term care policies and living and care arrangements of elderly persons, and as the co-principal investigator on another NIA-funded study developing game theoretical models of family long-term care decisions.
Her outcomes research portfolio includes analyses of the effects of patterns of breast cancer care on disease recurrence, mortality, quality of life and economic well-being; analyses of the relationship between guideline adherence, processes of care and outcomes in electrodiagnostic medicine; and two randomized controlled trials of behavioral interventions designed to (i) improve blood pressure control and (ii) self-management and reduce adverse events secondary to complex medication regimens among home health patients. Dr. Pezzin's research projects are funded by NCI, VA-HSR&D, NHLBI and AHRQ, respectively.
Publications
-
Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States.
(Lin M, Estrada-Merly N, Eapen M, Zamora AE, Pezzin LE, Winn AN, Philip J, Schinke C, Drobyski WR, Anderson LD Jr, D'Souza A.) Bone Marrow Transplant. 2023 Sep 06 PMID: 37673983 SCOPUS ID: 2-s2.0-85170080925 09/07/2023
-
Centralization of Initial Care and Improved Survival of Poor Patients With Breast Cancer.
(Nattinger AB, Bickell NA, Schymura MJ, Laud P, McGinley EL, Fergestrom N, Pezzin LE.) J Clin Oncol. 2023 Apr 10;41(11):2067-2075 PMID: 36603178 PMCID: PMC10419674 SCOPUS ID: 2-s2.0-85152169276 01/06/2023
-
Prevalence of Race/Ethnicity Reporting in Light Chain (AL) Amyloidosis Clinical Research in the USA.
(Lin M, Pezzin LE, Mohamedi A, Kansagra A, D'Souza A.) J Racial Ethn Health Disparities. 2023 Apr;10(2):644-650 PMID: 35106741 PMCID: PMC9339584 02/03/2022
-
Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer.
(Neuner JM, Fergestrom N, Pezzin LE, Laud PW, Ruddy KJ, Winn AN.) Breast Cancer Res Treat. 2023 Jan;197(1):223-233 PMID: 36357711 SCOPUS ID: 2-s2.0-85141681578 11/11/2022
-
(Abramoff BA, Dillingham TR, Brown LA, Caldera F, Caldwell KM, McLarney M, McGinley EL, Pezzin LE.) Arch Phys Med Rehabil. 2023 Jan;104(1):11-17 PMID: 36202227 PMCID: PMC9529350 10/07/2022
-
(Kallies K, Dillingham TR, Edelstein A, Hume E, Polsky D, Schwartz R, McGinley EL, Pezzin LE.) Arch Phys Med Rehabil. 2022 Dec;103(12):2398-2403 PMID: 35760109 PMCID: PMC9729363 06/28/2022
-
(Hentschel CB, Abramoff BA, Dillingham TR, Pezzin LE.) PM R. 2022 Nov;14(11):1315-1324 PMID: 35789541 PMCID: PMC9350262 07/06/2022
-
(Brown LA, Ballentine E, Zhu Y, McGinley EL, Pezzin L, Abramoff B.) Brain Behav Immun Health. 2022 Jul;22:100460 PMID: 35403066 PMCID: PMC8983478 04/12/2022
-
(Edelstein AI, Hume EL, Pezzin LE, McGinley EL, Dillingham TR.) J Bone Joint Surg Am. 2022 Mar 16;104(6):523-529 PMID: 34982740 PMCID: PMC8930731 01/05/2022
-
SARS-CoV-2 Cycle Thresholds, Poverty, Race, and Clinical Outcomes.
(Rivera F, Gmehlin CG, Pezzin LE, Hanson R, Perez A, Singh S, Ledeboer NA, Buchan BW, Nattinger AB, Munoz-Price LS.) WMJ. 2021 Dec;120(4):301-304 PMID: 35025178 SCOPUS ID: 2-s2.0-85123460891 01/14/2022
-
Inpatient Rehabilitation Outcomes After Severe COVID-19 Infections: A Retrospective Cohort Study.
(Abramoff BA, Dillingham TR, Caldera FE, Ritchie MD, Pezzin LE.) Am J Phys Med Rehabil. 2021 Dec 01;100(12):1109-1114 PMID: 34657085 PMCID: PMC8594383 10/18/2021
-
SARS-CoV-2 and Wisconsin Nursing Homes: Temporal Dynamics During the COVID-19 Pandemic.
(Gmehlin CG, Rivera F, Ramos-Castaneda JA, Pezzin LE, Ehn D, Duthie EH, Muñoz-Price LS.) J Am Med Dir Assoc. 2021 Nov;22(11):2233-2239 PMID: 34529958 PMCID: PMC8390373 SCOPUS ID: 2-s2.0-85115030245 09/17/2021